4Peters CA.Freeman MR.Fernandez CA.et al.Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease[J]. Am J Physiol, 1997.272(6pt2) :R1960-1965.
5Rasmussen HS.Mccann PP.Mtrix metalloproteinase inhibition as a novel anticancer strategy:a review with special focus on Batimastat and Marimastat[J].Pharmacol Ther. 1997,75 ( 1 ) : 69-75.
7Sedlacek R.Mauch S.Kolb B.et al.Matrix metalloproteinase MMP-19(RASI-1)is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis[J].Immunobiology 1998,198(4) ;408-423.
8Backer AH.Zaltsman AB.George SJ.et al.Divergent effects of tissue inhibitor of metalloproteinase -1-2 or -3 overexpression on rat vascular smooth muscle cell invasion proliferation and death in vitro[J].J Clin Invest 1998,101 (6):1478-1487.
9Greene J,Wang M,Lin YE.et al.Molecular cloning and characterization of human tissue inhibitor of metallopnteinases 4[J].J Biol Chem 1996.291 (48) :30375-30380.
10Gomez DE.Alonso DF.Yoshiji H,et al.Tissue inhibitors of metalloproteinases:Structure regulation and biological functions[J].Eur J Cell Biol 1997,74(2) : 111-122.
